Literature DB >> 26722278

Compound gastroenteropancreatic neuroendocrine and gastrointestinal stromal tumors in the stomach: A case report.

Y U Zhou1, Ping Chen1, Liang Zhong2.   

Abstract

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) combined with gastrointestinal stromal tumors (GISTs) are rarely observed in the clinic. In the present study, the case of a 56-year-old female diagnosed with compound GEP-NETs and GISTs was reported. The patient initially presented with epigastric discomfort. The pre-operative diagnosis was of GISTs based on the endoscopic and imaging findings. A subtotal gastrectomy and Roux-en-Y reconstruction were successfully performed. The final diagnosis was revised to be compound GEP-NETs and GISTs based on the pathological findings. After 17 months of follow-up examinations using computed tomography and ultrasonography, the patient showed no symptoms or signs of recurrence.

Entities:  

Keywords:  gastroenteropancreatic neuroendocrine tumors; gastrointestinal stromal tumors; stomach

Year:  2015        PMID: 26722278      PMCID: PMC4665847          DOI: 10.3892/ol.2015.3666

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  22 in total

Review 1.  The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.

Authors:  Simon Schimmack; Bernhard Svejda; Benjamin Lawrence; Mark Kidd; Irvin M Modlin
Journal:  Langenbecks Arch Surg       Date:  2011-01-28       Impact factor: 3.445

2.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.

Authors:  Günter Klöppel; Anne Couvelard; Aurel Perren; Paul Komminoth; Anne-Marie McNicol; Ola Nilsson; Aldo Scarpa; Jean-Yves Scoazec; Bertram Wiedenmann; Mauro Papotti; Guido Rindi; Ursula Plöckinger
Journal:  Neuroendocrinology       Date:  2009-08-28       Impact factor: 4.914

Review 3.  Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract.

Authors:  Günter Klöppel; Martin Anlauf
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-08       Impact factor: 3.043

Review 4.  Current knowledge on diagnosis and staging of neuroendocrine tumors.

Authors:  Kjell Oberg; Daniel Castellano
Journal:  Cancer Metastasis Rev       Date:  2011-03       Impact factor: 9.264

5.  DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.

Authors:  Yuchen Jiao; Chanjuan Shi; Barish H Edil; Roeland F de Wilde; David S Klimstra; Anirban Maitra; Richard D Schulick; Laura H Tang; Christopher L Wolfgang; Michael A Choti; Victor E Velculescu; Luis A Diaz; Bert Vogelstein; Kenneth W Kinzler; Ralph H Hruban; Nickolas Papadopoulos
Journal:  Science       Date:  2011-01-20       Impact factor: 47.728

6.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

Authors:  S Hirota; K Isozaki; Y Moriyama; K Hashimoto; T Nishida; S Ishiguro; K Kawano; M Hanada; A Kurata; M Takeda; G Muhammad Tunio; Y Matsuzawa; Y Kanakura; Y Shinomura; Y Kitamura
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

7.  Clinicopathological and immunohistochemical features of gastointestinal stromal tumors.

Authors:  Yu Na Kang; Hye Ra Jung; Ilseon Hwang
Journal:  Cancer Res Treat       Date:  2010-09-30       Impact factor: 4.679

Review 8.  Biology of gastrointestinal stromal tumors.

Authors:  Christopher L Corless; Jonathan A Fletcher; Michael C Heinrich
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

Review 9.  Management of gastrointestinal stromal tumors in the era of tyrosine kinase inhibitors.

Authors:  Suzanne George; Jayesh Desai
Journal:  Curr Treat Options Oncol       Date:  2002-12

10.  PDGFRA activating mutations in gastrointestinal stromal tumors.

Authors:  Michael C Heinrich; Christopher L Corless; Anette Duensing; Laura McGreevey; Chang-Jie Chen; Nora Joseph; Samuel Singer; Diana J Griffith; Andrea Haley; Ajia Town; George D Demetri; Christopher D M Fletcher; Jonathan A Fletcher
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.